Commonwealth Equity Services’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25.5M Sell
237,347
-16,017
-6% -$1.72M 0.03% 495
2025
Q1
$25.6M Buy
253,364
+25,449
+11% +$2.57M 0.04% 467
2024
Q4
$20.4M Buy
227,915
+16,054
+8% +$1.43M 0.03% 524
2024
Q3
$17.8M Buy
211,861
+392
+0.2% +$32.9K 0.03% 566
2024
Q2
$16.3M Buy
211,469
+8,780
+4% +$676K 0.03% 590
2024
Q1
$13.9M Sell
202,689
-4,612
-2% -$316K 0.02% 643
2023
Q4
$12M Buy
207,301
+5,937
+3% +$343K 0.02% 653
2023
Q3
$10.6M Buy
201,364
+13,121
+7% +$693K 0.02% 648
2023
Q2
$10.2M Buy
188,243
+46,423
+33% +$2.51M 0.02% 674
2023
Q1
$7.1K Sell
141,820
-2,761
-2% -$138 0.01% 836
2022
Q4
$6.69M Buy
144,581
+29,146
+25% +$1.35M 0.02% 821
2022
Q3
$4.47M Sell
115,435
-5,381
-4% -$208K 0.01% 942
2022
Q2
$4.5M Sell
120,816
-4,624
-4% -$172K 0.01% 950
2022
Q1
$5.56M Sell
125,440
-9,936
-7% -$440K 0.01% 901
2021
Q4
$5.75M Buy
135,376
+1,982
+1% +$84.2K 0.01% 862
2021
Q3
$5.79M Buy
133,394
+3,704
+3% +$161K 0.01% 795
2021
Q2
$5.55M Buy
129,690
+3,218
+3% +$138K 0.01% 806
2021
Q1
$4.89M Sell
126,472
-2,746
-2% -$106K 0.01% 794
2020
Q4
$4.65M Buy
129,218
+1,069
+0.8% +$38.4K 0.01% 754
2020
Q3
$4.9M Buy
128,149
+641
+0.5% +$24.5K 0.02% 651
2020
Q2
$4.48M Sell
127,508
-14,821
-10% -$520K 0.02% 644
2020
Q1
$4.64M Sell
142,329
-3,349
-2% -$109K 0.02% 578
2019
Q4
$6.59M Buy
145,678
+30,761
+27% +$1.39M 0.03% 539
2019
Q3
$4.68M Buy
114,917
+32,380
+39% +$1.32M 0.02% 621
2019
Q2
$3.55M Buy
82,537
+4,078
+5% +$175K 0.02% 691
2019
Q1
$3.01M Buy
78,459
+3,171
+4% +$122K 0.01% 738
2018
Q4
$2.66M Buy
75,288
+6,083
+9% +$215K 0.01% 709
2018
Q3
$2.66M Buy
69,205
+5,425
+9% +$209K 0.01% 794
2018
Q2
$2.09M Sell
63,780
-7,499
-11% -$245K 0.01% 881
2018
Q1
$1.95M Buy
71,279
+1,850
+3% +$50.5K 0.01% 880
2017
Q4
$1.72M Sell
69,429
-2,540
-4% -$63K 0.01% 932
2017
Q3
$2.1M Buy
71,969
+12,557
+21% +$366K 0.01% 781
2017
Q2
$1.65M Buy
59,412
+3,040
+5% +$84.3K 0.01% 888
2017
Q1
$1.4M Buy
56,372
+4,915
+10% +$122K 0.01% 943
2016
Q4
$1.11M Sell
51,457
-17
-0% -$368 0.01% 977
2016
Q3
$1.23M Sell
51,474
-209
-0.4% -$4.97K 0.01% 902
2016
Q2
$1.21M Buy
51,683
+316
+0.6% +$7.39K 0.01% 887
2016
Q1
$966K Buy
51,367
+246
+0.5% +$4.63K 0.01% 959
2015
Q4
$943K Buy
51,121
+6,464
+14% +$119K 0.01% 965
2015
Q3
$733K Sell
44,657
-8,399
-16% -$138K 0.01% 1039
2015
Q2
$939K Buy
53,056
+4,350
+9% +$77K 0.01% 994
2015
Q1
$865K Buy
48,706
+1,708
+4% +$30.3K 0.01% 1028
2014
Q4
$623K Buy
46,998
+7,436
+19% +$98.6K 0.01% 1142
2014
Q3
$467K Sell
39,562
-11,077
-22% -$131K 0.01% 1285
2014
Q2
$647K Buy
50,639
+10,513
+26% +$134K 0.01% 1090
2014
Q1
$543K Sell
40,126
-57,372
-59% -$776K 0.01% 1121
2013
Q4
$1.17M Sell
97,498
-15,582
-14% -$187K 0.02% 685
2013
Q3
$1.33M Sell
113,080
-15,077
-12% -$177K 0.02% 599
2013
Q2
$1.19M Buy
+128,157
New +$1.19M 0.02% 603